<span item_type="fundamental" item_id="fa1789cfaceeef406ef03f5b8be9680b" counter_id="ST/US/WGSWW" env="prod"></span><span item_type="announcement" item_id="576479454845470721" env="prod"></span><p>营收：截至 2025 财年 Q3，公布值为 1.17 亿美元。</p><p>每股收益：截至 2025 财年 Q3，公布值为 -0.27 美元。</p><p>息税前利润：截至 2025 财年 Q3，公布值为 -2.69 百万美元。</p><p></p><h3>收入</h3><ul><li>第三季度收入为 1.167 亿美元，同比增长 52%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>外显子组和基因组测试收入为 9890 万美元，同比增长 65%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li></ul><h3>外显子组和基因组测试量</h3><ul><li>外显子组和基因组测试结果量为 25,702，同比增长 33%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>毛利率</h3><ul><li>调整后的毛利率扩大至 74%，高于 2024 年第三季度的 64%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>GAAP 毛利率为 72%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>运营费用</h3><ul><li>调整后的总运营费用为 7120 万美元，占第三季度收入的 61%，相比 2024 年第三季度占收入的 62%。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>GAAP 运营费用为 8780 万美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>净收入</h3><ul><li>调整后的净收入为 1470 万美元，而 2024 年第三季度为 200 万美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>GAAP 净亏损为 760 万美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>现金流</h3><ul><li>第三季度自由现金流为 880 万美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li><li>截至 2025 年 9 月 30 日，现金、现金等价物、可出售证券和受限现金为 1.561 亿美元。<span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>通过 “市场发行” 销售 101,367 股 A 类普通股，扣除费用后获得 1180 万美元。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span></li></ul><h3>展望/指导</h3><ul><li>GeneDx 提高了 2025 年全年收入指导，预计收入在 4.25 亿至 4.28 亿美元之间，外显子组和基因组收入增长在 53% 至 55% 之间。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>调整后的毛利率预计在 70% 至 71% 之间。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li><li>调整后的净收入预计每季度和全年为正。<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025pressrelease.htm"></span><span class="superscript" item_id="0" item_type="announcement_file" value="2" url="https://www.sec.gov/Archives/edgar/data/1818331/000181833125000128/q32025earningspresentati.htm"></span></li></ul>

GeneDx - CW27｜8-K：2025 财年 Q3 营收 1.17 亿美元